For research use only. Not for therapeutic Use.
SSI-4(CAT: I040893) is an inhibitor of Stearoyl-CoA desaturase 1 (SCD1), an enzyme involved in the biosynthesis of monounsaturated fatty acids. By inhibiting SCD1, SSI-4 disrupts lipid metabolism, which can have therapeutic implications in conditions like obesity, insulin resistance, and cancer. When modified with the radioactive isotope 11C, SSI-4 can be used as a ligand in small animal PET/CT imaging, enabling the non-invasive visualization and quantification of SCD1 activity in vivo. This imaging capability makes SSI-4 a valuable tool in metabolic disease research, particularly in studying lipid metabolism and related disorders.
| CAS Number | 1875084-68-6 |
| Synonyms | 2-[[4-(2-chlorophenoxy)piperidine-1-carbonyl]amino]-N-methylpyridine-4-carboxamide |
| Molecular Formula | C19H21ClN4O3 |
| Purity | ≥95% |
| IUPAC Name | 2-[[4-(2-chlorophenoxy)piperidine-1-carbonyl]amino]-N-methylpyridine-4-carboxamide |
| InChI | InChI=1S/C19H21ClN4O3/c1-21-18(25)13-6-9-22-17(12-13)23-19(26)24-10-7-14(8-11-24)27-16-5-3-2-4-15(16)20/h2-6,9,12,14H,7-8,10-11H2,1H3,(H,21,25)(H,22,23,26) |
| InChIKey | WGKHWTRLHPIUGS-UHFFFAOYSA-N |
| SMILES | CNC(=O)C1=CC(=NC=C1)NC(=O)N2CCC(CC2)OC3=CC=CC=C3Cl |
